Figure 2 reveals data related to inflammatory biomarkers including PCT, CRP, ESR, and CPIS as scoring system for evaluating pneumonia in the patients with successful clinical response to treatment including 3 patients in colistin and 10 in ampicillin/sulbactam arms of the study. The gene discussed is CRP; the disease is susceptibility to pneumonia measurement.